Kallyope

kallyope.com

Kallyope is focused on addressing significant health challenges by discovering and developing effective oral therapeutics for metabolic, neurological, and gastrointestinal diseases. Utilizing their proprietary Klarity™ platform, they explore the gut-brain axis to create innovative treatments for conditions such as obesity, diabetes, and gastrointestinal disorders. With a team of accomplished scientists and drug developers based in New York City, Kallyope aims to deliver well-tolerated and easy-to-use therapies, positioning itself as a leader in the biopharmaceutical industry with a strong commitment to advancing human health.